Texans rank pharmacies as the most accessible healthcare destination and support policies that allow patient choice when it comes to accessing services, NACDS said.
Novartis AG agreed to pay $245 million to end antitrust litigation accusing the company of trying to delay the launch of generic versions of the drug Exforge in the United States.
Medicare Part D beneficiaries are now able to access reduced-cost monthly insulin supplies and free Shingrix vaccines at all Hy-Vee Pharmacy locations.
The Consolidated Appropriations Act will increase competition from generic and biosimilar medicines and enhance patient access to lower cost prescription drugs.